DE69127694T2 - Herstellung und verwendung von transfer-faktor - Google Patents
Herstellung und verwendung von transfer-faktorInfo
- Publication number
- DE69127694T2 DE69127694T2 DE69127694T DE69127694T DE69127694T2 DE 69127694 T2 DE69127694 T2 DE 69127694T2 DE 69127694 T DE69127694 T DE 69127694T DE 69127694 T DE69127694 T DE 69127694T DE 69127694 T2 DE69127694 T2 DE 69127694T2
- Authority
- DE
- Germany
- Prior art keywords
- transfer factor
- production
- substantially pure
- specific activity
- units per
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010074506 Transfer Factor Proteins 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000002835 absorbance Methods 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 239000013592 cell lysate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54750090A | 1990-07-02 | 1990-07-02 | |
US71857191A | 1991-06-26 | 1991-06-26 | |
PCT/US1991/004779 WO1992000093A1 (en) | 1990-07-02 | 1991-07-02 | Transfer factor and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69127694D1 DE69127694D1 (de) | 1997-10-23 |
DE69127694T2 true DE69127694T2 (de) | 1998-04-02 |
Family
ID=27068558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69127694T Expired - Fee Related DE69127694T2 (de) | 1990-07-02 | 1991-07-02 | Herstellung und verwendung von transfer-faktor |
Country Status (12)
Country | Link |
---|---|
US (2) | US5470835A (de) |
EP (1) | EP0537280B1 (de) |
JP (1) | JPH05508847A (de) |
KR (1) | KR0184598B1 (de) |
AT (1) | ATE158184T1 (de) |
AU (1) | AU657915B2 (de) |
CA (1) | CA2086610A1 (de) |
DE (1) | DE69127694T2 (de) |
DK (1) | DK0537280T3 (de) |
ES (1) | ES2106784T3 (de) |
GR (1) | GR3025282T3 (de) |
WO (1) | WO1992000093A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5883224A (en) * | 1996-04-19 | 1999-03-16 | Cytokine Sciences, Inc. | Characterization of transfer factors and methods of use |
US5858378A (en) * | 1996-05-02 | 1999-01-12 | Galagen, Inc. | Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen |
US6136794A (en) * | 1998-02-02 | 2000-10-24 | Merck & Co., Inc. | Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist |
US20020044942A1 (en) * | 2000-09-18 | 2002-04-18 | Chisolm Biological Laboratory, Llc | Transfer factor composition and process for producing same |
US6468534B1 (en) * | 2000-09-21 | 2002-10-22 | 4Life Research, Lc | Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use |
US20060073197A1 (en) * | 2004-05-20 | 2006-04-06 | Ramaekers Joseph C | Encapsulated transfer factor compositions and methods of use |
US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
US20070128253A1 (en) * | 2005-04-13 | 2007-06-07 | Ramaekers Joseph C | Encapsulated transfer factor compositions and methods of use |
MXPA02002171A (es) * | 2002-02-28 | 2002-12-09 | Antonio Calzada Nova Luis | Extracto de leucocitos dializado en la elaboracion de un farmaco para el tratamiento de enfermedades infecciosas en animales. |
WO2004017916A2 (en) * | 2002-08-22 | 2004-03-04 | 4Life Research, Lc | Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
WO2004041071A2 (en) * | 2002-11-04 | 2004-05-21 | 4Life Research, Lc | Compositions, systems, and methods for focusing a cell-mediated immune response |
US6866868B1 (en) * | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
CN100394178C (zh) * | 2006-01-23 | 2008-06-11 | 武汉海特生物制药股份有限公司 | 一种特异性转移因子主要有效成分含量的检测方法 |
CZ299296B6 (cs) * | 2006-06-13 | 2008-06-11 | Sevapharma A.S. | Lécivo transfer faktor - zpusob výroby a použití |
US20090053197A1 (en) * | 2006-06-14 | 2009-02-26 | Ramaekers Joseph C | Transfer Factor Compositions and Methods |
US9125874B2 (en) | 2007-11-30 | 2015-09-08 | The Ramaekers Family Trust | Administration of transfer factor for improving reproductive health |
WO2009039256A1 (en) * | 2007-09-18 | 2009-03-26 | Ramaekers Nutrition, Llc | Growth factor fraction compositions and methods |
EP2278984A4 (de) | 2007-11-30 | 2013-02-27 | Ramaekers Family Trust | Zusammensetzungen und verfahren zur verbesserung der fertilität |
EA034057B1 (ru) | 2010-11-23 | 2019-12-23 | Пантерикс, Инк. | Способ сокращения продолжительности диареи, вызванной кишечной инфекцией |
MX338863B (es) * | 2011-12-16 | 2016-05-01 | Inst Politecnico Nacional | Metodo de obtencion de extracto dializable de leucocitos. |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991182A (en) * | 1971-10-19 | 1976-11-09 | The Regents Of The University Of California | Transfer factor |
US4001080A (en) * | 1972-10-20 | 1977-01-04 | Piktor Limited | Production of immunological materials |
US3991132A (en) * | 1973-09-06 | 1976-11-09 | Ford Motor Company | Powder paint with epoxy and amide copolymer with anhydrides and hydroxy acids |
US4132776A (en) * | 1978-02-15 | 1979-01-02 | University Patents, Inc. | Delivery of immunologically active components of transfer factor |
IN150740B (de) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
US4468372A (en) * | 1980-03-20 | 1984-08-28 | Jakob Harich | Hygienic air purifying device |
NO156516C (no) * | 1980-05-14 | 1987-10-07 | A Arthur Gottlieb | Fremgangsmaate for fremstilling av modulatorer for immunsystemet. |
US4435384A (en) * | 1982-04-30 | 1984-03-06 | Viragen, Inc. | Transfer factor composition and skin treatment |
US4468379A (en) * | 1982-05-06 | 1984-08-28 | Endeavor Corp. | Leukocyte extracts for affecting the immune system |
EP0101200A3 (de) * | 1982-07-20 | 1985-03-06 | BIO-COM Inc. | Transferfaktor zur Anwendung in der Behandlung von Virusinfektionen |
US4816563A (en) * | 1983-11-25 | 1989-03-28 | Amtron, Inc. | Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof |
US4616079A (en) * | 1984-08-24 | 1986-10-07 | Imreg, Inc. | Immunoamplifiers and processes for the extraction thereof |
AU8107191A (en) * | 1990-07-02 | 1992-01-23 | National Jewish Center For Immunology And Respiratory Medicine | Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof |
-
1991
- 1991-07-02 AU AU81957/91A patent/AU657915B2/en not_active Ceased
- 1991-07-02 KR KR1019930700016A patent/KR0184598B1/ko not_active IP Right Cessation
- 1991-07-02 WO PCT/US1991/004779 patent/WO1992000093A1/en active IP Right Grant
- 1991-07-02 EP EP91913547A patent/EP0537280B1/de not_active Expired - Lifetime
- 1991-07-02 CA CA002086610A patent/CA2086610A1/en not_active Abandoned
- 1991-07-02 DK DK91913547.5T patent/DK0537280T3/da active
- 1991-07-02 JP JP91512313A patent/JPH05508847A/ja active Pending
- 1991-07-02 AT AT91913547T patent/ATE158184T1/de not_active IP Right Cessation
- 1991-07-02 ES ES91913547T patent/ES2106784T3/es not_active Expired - Lifetime
- 1991-07-02 DE DE69127694T patent/DE69127694T2/de not_active Expired - Fee Related
-
1994
- 1994-07-22 US US08/279,278 patent/US5470835A/en not_active Expired - Fee Related
-
1995
- 1995-05-16 US US08/441,973 patent/US5840700A/en not_active Expired - Fee Related
-
1997
- 1997-11-05 GR GR970402920T patent/GR3025282T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU8195791A (en) | 1992-01-23 |
EP0537280A4 (en) | 1993-09-08 |
US5470835A (en) | 1995-11-28 |
WO1992000093A1 (en) | 1992-01-09 |
CA2086610A1 (en) | 1992-01-03 |
ATE158184T1 (de) | 1997-10-15 |
EP0537280A1 (de) | 1993-04-21 |
DE69127694D1 (de) | 1997-10-23 |
US5840700A (en) | 1998-11-24 |
DK0537280T3 (da) | 1997-10-13 |
GR3025282T3 (en) | 1998-02-27 |
JPH05508847A (ja) | 1993-12-09 |
ES2106784T3 (es) | 1997-11-16 |
KR0184598B1 (ko) | 1999-05-01 |
AU657915B2 (en) | 1995-03-30 |
EP0537280B1 (de) | 1997-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69127694D1 (de) | Herstellung und verwendung von transfer-faktor | |
ATE45942T1 (de) | Diarylacetylene, ihre herstellung und verwendung. | |
ATE83659T1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
DE3576331D1 (de) | Tetralin-derivate, ihre herstellung und verwendung. | |
ATE136777T1 (de) | Behandlung von schlafstörungen unter verwendung bestimmter antidepressiva, z.b. nefazodon | |
GR3019957T3 (en) | Derivatives of substituted cyclohexane, their process of preparation and their application with the treatment of diseases | |
ATE184193T1 (de) | Verwendung von n-acylaminoalkoholen zur herstellung eines arzneimittels zur behandlung von mastzellerkrankungen | |
ATE65402T1 (de) | Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung. | |
DE69130497D1 (de) | Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis | |
DE3764559D1 (de) | 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung. | |
ATE247474T1 (de) | Verwendung von inosittriphosphat zur herstellung von arzneimitteln | |
DE59010865D1 (de) | N-substituierte naphthalimide, ihre herstellung und verwendung | |
ATE125270T1 (de) | Tert-butyloxycarbonyl-l-tyrosyl- peptidoglycanmonomer und deren 125 i-markiertes derivat, deren herstellung und verwendung. | |
ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
PT85602A (en) | Oxolabdanes a process for their preparation and their use as medicaments | |
DE69021557T2 (de) | Verwendung von derivaten von 9,10-dihydrophenanthren zur herstellung eines antitumoralen medikamentes und neuen derivaten daraus. | |
HU908017D0 (en) | Process for the preparation of naphloxazines and medical preparation made of them | |
DE59202744D1 (de) | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung. | |
DE3372970D1 (en) | 6-alpha-methyl-prednisolone derivatives, their preparation and utilization | |
DE59208712D1 (de) | Neue cytarabin-derivate, ihre herstellung und verwendung | |
ATE33020T1 (de) | 10,11-dihydro-5h-dibenzo(a,d>cycloheptadienderivate, ihre herstellung und verwendung. | |
ATA270188A (de) | Enantiomerenreine zwischenprodukte, deren herstellung und deren verwendung zur herstellung von enantiomerenreinem disparlure | |
ZA868404B (en) | Pharmaceutical compositions for use in improving oxygenation of the brain and a process for their production | |
IT1256237B (it) | Procedimento per la preparazione di acyclovir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |